Enanta Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:ENTA) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 398.82 M376.65 M348.64 M322.99 M301.03 M280.73 M329.5 M Total liabilities 249.91 M247.84 M236.83 M229.46 M221.75 M216.01 M202.91 M Total equity 148.91 M128.81 M111.82 M93.54 M79.28 M64.72 M126.59 M Total liabilities & shareholders' equities 398.82 M376.65 M348.64 M322.99 M301.03 M280.73 M329.5 M Total debt ——————— Net debt ———————

Haberler

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Enanta earnings beat by $0.39, revenue topped estimates

Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Baird, Enanta Pharmaceuticals hissesi için Üstün Performans notunu yineledi

Baird reiterates Outperform rating on Enanta Pharmaceuticals stock

Enanta, RSV ve immünoloji portföyünde önemli kilometre taşlarıyla ilerliyor

Enanta advances RSV and immunology pipeline with key milestones ahead

Agios Pharmaceuticals (AGIO) Surges 18.6%: Is This an Indication of Further Gains?

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?

Enanta Pharma CSO Or Yat Sun sells $34k in stock

Enanta Pharma CBO Luu sells $19,836 in stock